FDA guidance and policy
Clear overviews of the documents, expectations, and policy shifts shaping pharmaceutical quality and regulatory work.
A Tailwind Pharma media property
The Regulatory Mix
Where sound and AI meet CGMPs, and CGMPs meet practice — in pharma and beyond.
A practical briefing on FDA guidance, cGMP expectations, public enforcement actions, and the real-world developments shaping pharmaceutical manufacturing and compounding.
FDA
Guidance and enforcement
cGMP
Manufacturing and quality systems
Practical
Context for regulated teams
01 · About the Show
A clearer signal in a dense regulatory landscape
Pharmaceutical regulation, translated for the people responsible for quality. The Regulatory Mix is an all-in-one briefing on FDA guidance, current Good Manufacturing Practices, and the events that shape them. Episodes pair clear overviews with deeper analysis of public documents, FDA Warning Letters, and developments across pharmaceutical manufacturing and compounding.
The show is made for seasoned professionals, quality-minded newcomers, and anyone curious about the rules behind drug manufacturing. Dense regulatory language becomes practical context teams can carry into their work.
The goal is not more regulatory noise. It is a more useful understanding of what matters and why.
02 · What You’ll Hear
The issues behind today’s quality decisions
Each topic is approached as a working issue for regulated teams — not simply a headline or a summary of agency language.
Warning Letters and enforcement
Practical discussion of public FDA actions and what the underlying observations can teach quality and operations teams.
cGMP and manufacturing practice
Focused analysis of current Good Manufacturing Practices, inspection readiness, data integrity, and quality-system execution.
Pharmaceutical and compounding developments
Noteworthy developments affecting manufacturers, CDMOs, and the 503A and 503B compounding environment.
03 · Listen and Follow
Choose the platform that fits your routine
Listen in your podcast app, follow Regulatory Mix on LinkedIn, or add the RSS feed directly to your preferred reader.
Regulatory Mix informs. Tailwind Pharma advises.
When the issue moves from discussion to action
The podcast provides general information. Tailwind Pharma provides direct consulting support for FDA inspections, observations, enforcement responses, remediation, and complex quality decisions.
Informational disclaimer: The Regulatory Mix is for informational and entertainment purposes only. Host interpretations may differ from official regulations or final agency positions. Consult a qualified regulatory professional for compliance decisions.